Free press releases distribution network?

Agency / Source: rfXcel Corporation

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



CorePharma Selects rfXcel for California ePedigree Compliance - Pharmaceutical Industry's Easiest to Use and Most Production-Proven E-Pedigree Solution to Insure California Compliance for CorePharma
CorePharma Selects rfXcel for California ePedigree Compliance

 

PRZOOM - /newswire/ - San Ramon, CA, United States, 2008/01/21 - Pharmaceutical Industry's Easiest to Use and Most Production-Proven E-Pedigree Solution to Insure California Compliance for CorePharma.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

rfXcel Corporation, a leading provider of ePedigree Management solutions that allow manufacturers, distributors, and retailers to track the chain of custody of prescription drugs through the pharmaceutical supply chain, today announced that CorePharma has selected rfXcel’s ePedigree Management solution to protect its supply chain from the threat of counterfeit drugs.

Based in Middlesex, NJ, CorePharma is a generic pharmaceutical manufacturer of prescription and over-the-counter products. CorePharma was established in 1998 and has US FDA registered facilities, in compliance with cGMP, EPA, and local government regulations.

In preparation for compliance with California’s pending 2009 ePedigree requirements, CorePharma selected rfXcel’s ePedigree Management solution, after evaluating the leading ePedigree software providers. rfXcel was selected for its certified conformance to the EPCglobal Drug Pedigree Standard, and its successful track record in getting its existing customers into production, generating Pedigrees for all 50 states. rfXcel’s rich set of features, and the ease with which it is to implement, integrate and use, put it’s solution over the top. Seamlessly integrating to CorePharma’s back-end systems will result in a fully automated system with minimal disruption to its current business processes.

“In selecting rfXcel’s production-proven and EPCglobal certified ePedigree Management solution, CorePharma has taken a major step forward in securing its supply chain from the threat of counterfeits”, said Glenn Abood, Founder and CEO at rfXcel. “With the challenges associated with complying with the 2009 California ePedigree and Serialization requirements, CorePharma chose to protect its drug products with a solution that provides them the greatest value at the lowest Total Cost of Ownership”.

About rfXcel Corporation

rfXcel, founded in 2003, is headquartered in San Ramon, CA. rfXcel (rfxcel.com) is a pioneer in creating real-time supply-chain performance improvement applications for retailers, manufacturers and distributors. rfXcel solutions can be implemented today, yet have the capability to scale as infrastructure technology develops. The rfXcel management team and board are comprised of industry experts that come directly from the life sciences, technology and consumer goods industries. rfXcel was founded on the principal of providing real business value to our customers by developing solutions that solve supply chain problems that they face every business day.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: rfXcel Corporation

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


CorePharma Selects rfXcel for California ePedigree Compliance

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Jim Ensell - rfXcel.com 
925-325-0584 jensell[.]rfxcel.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any rfXcel Corporation securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From rfXcel Corporation / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine
Somatuline® Autogel® 120 Mg Receives Japanese Approval for A New Indication for the Treatment of Gastro-entero-pancreatic Neuroendocrine Tumors
OTC Topical Drugs Market Size will Grow Profitably in the Near Future 2017-2025 Finds PMR
Bioinformatics Market Size to Expand at 20.4% CAGR through 2020 Reports Persistence Market Research
Australia Nitric Acid Market Expected to Reach at Value of $1.3B by 2024 End Says PMR
Commodity Chemicals Market Projected to be Resilient by 2020 Says Persistence Market Research
Cell Expansion Market Set to Garner Staggering Revenues by 2025 Reports PMR
Soft Tissue Sarcoma Treatment Market Revenue Predicted To Go Up by 2025 Finds Persistence Market Research

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  Rapid Recovery

Visit  BizJobs.com

Visit  MagLar, Inc.







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today